Scientific Publications
11Mar, 2016
Tramiprosate, an oral amyloid anti-aggregation agent, shows robust cognitive efficacy in APOE4/4 homozygous AD patients: efficacy and safety analyses from two Phase 3 trials
Presented at the 14th Annual International Athens/Springfield Symposium on Advances in Alzheimer Therapies [...]
27Oct, 2015
Cognitive and Functional Efficacy of Tramiprosate in APOE4+ Patients with Mild to Moderate Alzheimer’s Disease: Subgroup Analyses of the Phase 3 North American and European Trials
Presented at the 8th Clinical Trials on Alzheimer’s Disease Congress in Barcelona, Spain [...]
20Mar, 2015
Analyses of tramiprosate Phase 3 trials show improvement in cognition and function in APOE4 positive alzheimer’s disease subjects reaching 4 point improvement from placebo on ADAS-cog in homozygous APOE4 subjects, and support development of ALZ-801, a novel prodrug of tramiprosate with optimized drug properties
Presented at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases in Nice, France. [...]